http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100425281-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-54 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-60 |
| filingDate | 2000-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100425281-B1 |
| titleOfInvention | Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| abstract | The present invention relates to pyrimidinedione derivatives and pharmaceutically acceptable salts thereof useful as antiviral agents, in particular for the treatment of acquired immunodeficiency syndrome (AIDS). The present invention also relates to methods of preparing such compounds and pharmaceutical compositions containing such compounds as active ingredients.n n n (I)n n n R in the general formula (I) is cyclopropyl; Cyclobutyl; Cyclohexyl group; Hydroxyl group, C 1 ~C 4 alkyl group, C 1 ~C 4 alkoxy group, a halogen atom, a trifluoromethyl group, a cyano group, a single group selected from an amino group, a double or a substituted or unsubstituted phenyl group triplet; 1 or 2-naphthyl group; 9-anthracenyl group; 2-anthraquinone group; An alkoxy group of C 1 ~C 4 alkyl group, C 1 ~C 4, the cyano group or a halogen atom is substituted or unsubstituted pyridine group; 2, 3 or 4-quinoline group; Oxirane groups; 1-benzotriazole group; 2-benzoxazole group; Alkoxycarbonyl group substituted furanyl group of the C 1 ~C 4; Alkyl group of C 1 ~C 4; Or a benzoyl group.n n n R 1 represents a halogen atom or a C 1 to C 4 alkyl group.n n n R 2 and R 3 each independently represent a hydrogen atom or an alkyl group having 1 to 4 carbon atoms.n n n X represents an oxygen atom, Y represents an oxygen atom, a sulfur atom or a carbonyl group. |
| priorityDate | 1999-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 429.